Truist reiterates American Express stock rating on spending momentum

Truist reiterated a Buy on American Express with a $360 price target (down from $400) and nudged 2026 EPS to $18.00 (+1%), citing proprietary card-spend data showing modestly accelerating Q1 growth and strength in travel & leisure. AXP shares are down 19.4% YTD, trading at $299.59 versus a $387.49 52-week high, and InvestingPro flags the stock as potentially undervalued. Wolfe Research left its Peerperform rating unchanged. Company-level catalysts include a multi-year NFL global payments partnership starting 2026, the new Graphite Business Cash Unlimited card (unlimited 2% back; 5% on flights/hotels via AmEx Travel; $295 annual fee) and plans for eight new/enhanced business products in 2026.

Analysis

AmEx is positioned to disproportionately capture a travel-led rebound because premium cardholders concentrate spending seasonally and have higher wallet-share elasticity versus mass-market users; incremental travel spend flows through higher-margin merchant categories (air, hotels, travel agents) and into fee-bearing co-brand ecosystems, amplifying revenue per dollar of swiped volume. Management’s move to smooth the variable customer engagement metric is a signal they expect steadier collectability of rewards liability and potentially a more predictable drag on NII/fee math — that makes near-term beats easier to operationalize but raises the bar for visible upside on future cadence beats.

Second-order effects: the NFL partnership and targeted SMB product rollout create distinct margin and data advantages — exclusive presale/experience channels increase interchange yield and deepen 1st-party behavioral data, which improves cross-sell ROI and pricing power for lending products. Conversely, the new SMB cash card with a material annual fee is a two-edged sword: it can seed durable commercial spend but risks cannibalizing mid-tier product economics and invites competitor rate/promotional responses that could raise marketing spend over 12–24 months.

Key risks cluster by horizon: over days–weeks, prints that miss Truist’s implied momentum (billed business) will reprice sentiment quickly; over 3–12 months, macro shocks (recession, a sharp rise in unemployment) or regulatory pressure on merchant fees would compress spreads; over 1–3 years, AI-driven structural declines in business travel are the largest asymmetric tail. The clearest catalyst set: upcoming quarterly billed-business release and staged 2026 product rollouts — both are binary for re-rating given current valuation complacency priced into cyclical recovery expectations.

Key Decisions for Investors

• Tactical bullish: Buy AXP 6–9 month call spread (size to risk ≤2% portfolio) to capture the billed-business print and travel-season momentum. Target 25–35% upside to long-equity-equivalent if billed volume beats; set tactical stop at 50% of premium paid.
• Event hedge: If holding equity, buy 1–2% notional of 3–6 month puts as downside protection through the quarter-close; this cheapens stress protection versus outright cash exposure while preserving upside from a positive surprise.
• Relative trade (12 months): Pair long AXP / short COF (1:1 notional) to isolate premium-card cyclical strength versus broader consumer credit cyclicality. Expect 8–12% relative outperformance if travel and high-value card mix sustain; risk is idiosyncratic regulatory action hitting interchange across the board.
• Convex long: Accumulate AXP on >10% pullbacks into any miss, but stagger entries to capture reacceleration; be prepared to trim into rallies above 20–30% from entry or after clear 2026 product monetization milestones are achieved.